NO304672B1 - Anvendelse av NADH og NADPH som energierstatningprodukter - Google Patents
Anvendelse av NADH og NADPH som energierstatningprodukter Download PDFInfo
- Publication number
- NO304672B1 NO304672B1 NO920315A NO920315A NO304672B1 NO 304672 B1 NO304672 B1 NO 304672B1 NO 920315 A NO920315 A NO 920315A NO 920315 A NO920315 A NO 920315A NO 304672 B1 NO304672 B1 NO 304672B1
- Authority
- NO
- Norway
- Prior art keywords
- nadh
- nadph
- adenine dinucleotide
- nicotinamide adenine
- reduced form
- Prior art date
Links
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 title claims abstract description 47
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 title claims abstract description 22
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 title 1
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 claims abstract description 26
- 241001465754 Metazoa Species 0.000 claims abstract description 15
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims abstract description 9
- 229950006238 nadide Drugs 0.000 claims abstract description 9
- 241000282412 Homo Species 0.000 claims abstract description 8
- 150000001875 compounds Chemical class 0.000 claims description 10
- 235000013305 food Nutrition 0.000 claims description 8
- 230000037396 body weight Effects 0.000 claims description 7
- 239000000654 additive Substances 0.000 claims 2
- 230000000996 additive effect Effects 0.000 claims 2
- 239000000126 substance Substances 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 6
- 229960001456 adenosine triphosphate Drugs 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000002354 daily effect Effects 0.000 description 4
- 244000299461 Theobroma cacao Species 0.000 description 3
- 235000019219 chocolate Nutrition 0.000 description 3
- 230000003442 weekly effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 241000777300 Congiopodidae Species 0.000 description 1
- 229940124325 anabolic agent Drugs 0.000 description 1
- 239000003263 anabolic agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/153—Nucleic acids; Hydrolysis products or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Detergent Compositions (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Dental Preparations (AREA)
- Non-Alcoholic Beverages (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4102240A DE4102240C1 (es) | 1991-01-24 | 1991-01-24 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO920315D0 NO920315D0 (no) | 1992-01-23 |
| NO920315L NO920315L (no) | 1992-07-27 |
| NO304672B1 true NO304672B1 (no) | 1999-02-01 |
Family
ID=6423720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO920315A NO304672B1 (no) | 1991-01-24 | 1992-01-23 | Anvendelse av NADH og NADPH som energierstatningprodukter |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0496479B1 (es) |
| JP (1) | JP2533709B2 (es) |
| AT (1) | ATE112664T1 (es) |
| AU (1) | AU663479B2 (es) |
| BR (1) | BR9200207A (es) |
| CA (1) | CA2059510C (es) |
| DE (2) | DE4102240C1 (es) |
| DK (1) | DK0496479T3 (es) |
| ES (1) | ES2061313T3 (es) |
| FI (1) | FI920323A (es) |
| HU (1) | HU9200213D0 (es) |
| IE (1) | IE69861B1 (es) |
| NO (1) | NO304672B1 (es) |
| ZA (1) | ZA92275B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2167104A1 (en) * | 1995-01-17 | 1996-07-18 | Joerg G.D. Birkmayer | Nadh and nadph therapeutic agents for nasal, sublingual, rectal and dermal administration |
| US5712259A (en) * | 1996-04-22 | 1998-01-27 | Birkmayer Pharmaceuticals | NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome |
| US5668114A (en) * | 1996-05-08 | 1997-09-16 | Birkmayer Pharmaceuticals | NADH and NADPH pharmaceuticals for treating hypertension |
| IT1318565B1 (it) * | 2000-06-09 | 2003-08-27 | World Pharma Tech Ltd | Integratore alimentare proenergetico a base di nadh octocosanolo evitamina e. |
| US20040126751A1 (en) * | 2002-12-27 | 2004-07-01 | Birkmayer Jorg G.D. | Method of prolonging the life-span of living cells using NADH, NADPH and ADP-ribose |
| DE102008010245B4 (de) * | 2008-02-20 | 2011-02-10 | Emag Holding Gmbh | Verfahren zum Schleifen wellenförmiger Werkstücke |
| DE102014103443A1 (de) * | 2014-03-13 | 2015-09-17 | Jürgen Ruhlmann | Komposition zur Verwendung zur Behandlung von Müdigkeit, Konzentrationsschwäche, Entzugserscheinungen, Kopfschmerzen und Erkältungskrankheiten, insbesondere Leistungsabfall, Kater und Müdigkeit |
| KR102306818B1 (ko) * | 2018-07-26 | 2021-09-30 | 오리진 바이오테크놀로지 가부시키가이샤 | 기능성 계란 및 그 생산 방법 |
| DE202022000567U1 (de) | 2022-03-06 | 2022-03-16 | Penta Phi Eg | Liposomale Formulierung |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3594475A (en) * | 1968-04-24 | 1971-07-20 | Kyowa Hakko Kogyo Kk | Method of treating and preventing the side effects of antibiotics |
| EP0107161B1 (de) * | 1982-10-26 | 1989-08-09 | CTA Finanz AG | Mittel und Verfahren zur Optimierung der Gewebemasse von Organen innerhalb der genetischen Schwankungsbreite bei Menschen und Tieren |
| IT1162938B (it) * | 1983-08-26 | 1987-04-01 | Dino Spisni | Composizione per la cura dei tumori maligni in particolare sugli animali |
| JPS60126220A (ja) * | 1983-12-09 | 1985-07-05 | Otsuka Pharmaceut Factory Inc | 核酸成分組成物 |
| ES2007350A6 (es) * | 1987-05-29 | 1989-06-16 | Ganadera Union Ind Agro | Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion. |
| US4970200A (en) * | 1988-03-01 | 1990-11-13 | Schering Aktiengesellschaft | Agent for treatment of Parkinson's disease |
| AT397201B (de) * | 1988-06-03 | 1994-02-25 | Birkmayer Joerg Ddr | Verwendung des enzym-cofaktors nadph zur herstellung eines arzneimittels |
-
1991
- 1991-01-24 DE DE4102240A patent/DE4102240C1/de not_active Expired - Lifetime
- 1991-12-27 JP JP3345766A patent/JP2533709B2/ja not_active Expired - Fee Related
-
1992
- 1992-01-06 DE DE59200603T patent/DE59200603D1/de not_active Expired - Fee Related
- 1992-01-06 EP EP92250002A patent/EP0496479B1/de not_active Expired - Lifetime
- 1992-01-06 AT AT92250002T patent/ATE112664T1/de not_active IP Right Cessation
- 1992-01-06 DK DK92250002.0T patent/DK0496479T3/da active
- 1992-01-06 ES ES92250002T patent/ES2061313T3/es not_active Expired - Lifetime
- 1992-01-14 ZA ZA92275A patent/ZA92275B/xx unknown
- 1992-01-16 CA CA002059510A patent/CA2059510C/en not_active Expired - Fee Related
- 1992-01-23 HU HU9200213A patent/HU9200213D0/hu unknown
- 1992-01-23 IE IE920198A patent/IE69861B1/en not_active IP Right Cessation
- 1992-01-23 BR BR929200207A patent/BR9200207A/pt not_active Application Discontinuation
- 1992-01-23 NO NO920315A patent/NO304672B1/no not_active IP Right Cessation
- 1992-01-23 AU AU10392/92A patent/AU663479B2/en not_active Ceased
- 1992-01-24 FI FI920323A patent/FI920323A/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IE69861B1 (en) | 1996-10-16 |
| AU1039292A (en) | 1992-07-30 |
| ES2061313T3 (es) | 1994-12-01 |
| CA2059510A1 (en) | 1992-07-25 |
| FI920323A0 (fi) | 1992-01-24 |
| EP0496479B1 (de) | 1994-10-12 |
| NO920315L (no) | 1992-07-27 |
| BR9200207A (pt) | 1992-10-06 |
| NO920315D0 (no) | 1992-01-23 |
| CA2059510C (en) | 1997-06-10 |
| HU9200213D0 (en) | 1992-04-28 |
| ZA92275B (en) | 1992-12-30 |
| AU663479B2 (en) | 1995-10-12 |
| DE59200603D1 (de) | 1994-11-17 |
| JP2533709B2 (ja) | 1996-09-11 |
| DK0496479T3 (da) | 1995-04-18 |
| JPH05262652A (ja) | 1993-10-12 |
| IE920198A1 (en) | 1992-07-29 |
| DE4102240C1 (es) | 1992-04-09 |
| FI920323A (fi) | 1992-07-25 |
| EP0496479A1 (de) | 1992-07-29 |
| ATE112664T1 (de) | 1994-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Young | Growth and diabetes in normal animals treated with pituitary (anterior lobe) diabetogenic extract | |
| Westerfeld et al. | Metabolism and caloric value of alcohol | |
| EP0669083B1 (en) | Creatine beverage and producing process thereof | |
| JP2593882B2 (ja) | エネルギー補給用スポーツ飲料 | |
| CN102448452A (zh) | 用于支持糖尿病治疗的包含α-酮酸的膳食补充剂 | |
| CN101454000A (zh) | 含有氨基酸组合物的抗疲劳剂 | |
| JP2009503003A (ja) | グアニジノ酢酸成分をベースとする液体配合物 | |
| NO304672B1 (no) | Anvendelse av NADH og NADPH som energierstatningprodukter | |
| CN101703246A (zh) | 一种运动补充组合物 | |
| TRUSWELL et al. | Effects of amino acid supplements on the nutritive value of maize protein for human adults | |
| AU782479B2 (en) | Dietary supplement energy-providing to skeletal muscles and protecting the cardiovascular tract | |
| Ureta et al. | Inhibition by catecholamines of the induction of rat liver glucokinase | |
| KR100613618B1 (ko) | 운동에 동반하여 일어나는 산화적 대사를 지속시키는 방법 및스포츠용 음식물 | |
| WO2001093692A2 (en) | New canine beverage | |
| PT1093337E (pt) | Suplemento alimentar compreendendo ácido lipóico e creatina e métodos para a sua utilização | |
| Hargrove et al. | Kittens choose a high leucine diet even when isoleucine and valine are the limiting amino acids | |
| Nick | Creatine Phosphate Complex and Creatine Serum.(Medicinal Properties in Whole Foods). | |
| UA127073C2 (uk) | Суміш геродієтичного призначення для ентерального харчування осіб із захворюванням на цукровий діабет | |
| Terashima et al. | Plasma glucose clearance and insulin response to glucose infusion in wethers fed a low magnesium and/or high potassium diet | |
| Barys | Sports Nutrition: Critical Components for Optimal Performance | |
| Masushige et al. | Biological activities of riboflavin-dibutyrates in rats | |
| CZ5849U1 (cs) | Speciální přírodní stimulant organizmu | |
| Cox | Consumption of a combined glucose-NaCl solution during normal and food deprivation conditions | |
| Dreyer | The biological assessment of protein quality: sequential studies of urinary nitrogen excretion in the ablino rat under dietary conditions Part 3 | |
| Stevens | Does Alcohol Afford Nutrition to the Animal Tissues? |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN JULY 2003 |